HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Givaudan

This article was originally published in The Rose Sheet

Executive Summary

B2B flavors and fragrance site will target small to mid-tier clientele representing an estimated $2.33 bil.-$3.49 bil. (CH1=$.58) in market sales, which will provide "significant growth opportunity" for Givaudan, Swiss fragrance house says. GivaudanAccess.com will target broader range of customers by allowing them to purchase flavors and fragrances online while providing access to firm's creative services and product development, company maintains. Site will debut in North America in July followed by European launch slated for November

You may also be interested in...



Givaudan B2B Program To Access 10% Market Share In North America

Givaudan's recently-launched business-to-business Internet initiative, GivaudanAccess, is expected to help the company gain a 10% share of the North American fragrance and flavors market of small to mid-sized companies by 2005.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009152

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel